{"id":"https://openalex.org/W2091297212","doi":"https://doi.org/10.1016/j.nbd.2014.04.003","title":"The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","display_name":"The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","publication_year":2014,"publication_date":"2014-04-16","ids":{"openalex":"https://openalex.org/W2091297212","doi":"https://doi.org/10.1016/j.nbd.2014.04.003","mag":"2091297212","pmid":"https://pubmed.ncbi.nlm.nih.gov/24746855","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7254878"},"language":"en","primary_location":{"id":"doi:10.1016/j.nbd.2014.04.003","doi":"https://doi.org/10.1016/j.nbd.2014.04.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nbd.2014.04.003","pdf_url":null,"source":{"id":"https://openalex.org/S35878148","display_name":"Neurobiology of Disease","issn_l":"0969-9961","issn":["0969-9961","1095-953X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurobiology of Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7254878","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082780340","display_name":"Mari H. Savolainen","orcid":"https://orcid.org/0000-0001-7610-2909","observed_orcids":["https://orcid.org/0000-0001-7610-2909"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI","US"],"is_corresponding":false,"raw_author_name":"Mari H. Savolainen","raw_affiliation_strings":["Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland; Optogenetics and Transgenic Technology Core, National Institute of Drug Abuse, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland; Optogenetics and Transgenic Technology Core, National Institute of Drug Abuse, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1327069482","https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086681709","display_name":"Christopher T. Richie","orcid":"https://orcid.org/0000-0002-7944-4928","observed_orcids":["https://orcid.org/0000-0002-7944-4928"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher T. Richie","raw_affiliation_strings":["Optogenetics and Transgenic Technology Core, National Institute of Drug Abuse, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optogenetics and Transgenic Technology Core, National Institute of Drug Abuse, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108880617","display_name":"Brandon K. Harvey","orcid":"https://orcid.org/0000-0002-4036-1383","observed_orcids":["https://orcid.org/0000-0002-4036-1383","https://orcid.org/0000-0002-7471-9937"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon K. Harvey","raw_affiliation_strings":["Optogenetics and Transgenic Technology Core, National Institute of Drug Abuse, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optogenetics and Transgenic Technology Core, National Institute of Drug Abuse, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015022975","display_name":"Pekka T. M\u00e4nnist\u00f6","orcid":"https://orcid.org/0000-0002-8708-1979","observed_orcids":["https://orcid.org/0000-0002-8708-1979"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Pekka T. M\u00e4nnist\u00f6","raw_affiliation_strings":["Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069458729","display_name":"Kathleen A. Maguire\u2010Zeiss","orcid":"https://orcid.org/0000-0002-2868-848X","observed_orcids":["https://orcid.org/0000-0002-2868-848X"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen A. Maguire-Zeiss","raw_affiliation_strings":["Department of Neuroscience, Georgetown University Medical Center, Washington DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Georgetown University Medical Center, Washington DC, USA","institution_ids":["https://openalex.org/I2799903593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078817501","display_name":"Timo T. My\u00f6h\u00e4nen","orcid":"https://orcid.org/0000-0002-9277-6687","observed_orcids":["https://orcid.org/0000-0002-9277-6687"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["FI","US"],"is_corresponding":false,"raw_author_name":"Timo T. My\u00f6h\u00e4nen","raw_affiliation_strings":["Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland; Department of Neuroscience, Georgetown University Medical Center, Washington DC, USA. Electronic address: timo.myohanen@helsinki.fi","Department of Neuroscience, Georgetown University Medical Center, Washington DC, USA","Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland; Department of Neuroscience, Georgetown University Medical Center, Washington DC, USA. Electronic address: timo.myohanen@helsinki.fi","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2799903593"]},{"raw_affiliation_string":"Department of Neuroscience, Georgetown University Medical Center, Washington DC, USA","institution_ids":["https://openalex.org/I2799903593"]},{"raw_affiliation_string":"Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Finland","institution_ids":["https://openalex.org/I133731052"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4180,"currency":"USD","value_usd":4180},"apc_paid":null,"fwci":4.7782,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.94978536,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"68","issue":null,"first_page":"1","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prolyl-oligopeptidase","display_name":"prolyl oligopeptidase","score":0.9449999928474426},{"id":"https://openalex.org/keywords/alpha-synuclein","display_name":"alpha-synuclein","score":0.9509999752044678},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.5920000076293945},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/synucleinopathies","display_name":"synucleinopathies","score":0.7910000085830688},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8709999918937683},{"id":"https://openalex.org/keywords/a30p-mutation","display_name":"A30P mutation","score":0.7770000100135803},{"id":"https://openalex.org/keywords/beclin-1","display_name":"Beclin-1","score":0.9340000152587891},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.699999988079071},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.7630000114440918},{"id":"https://openalex.org/keywords/protein-clearance","display_name":"protein clearance","score":0.4230000078678131}],"concepts":[{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.9409699440002441},{"id":"https://openalex.org/C2777440831","wikidata":"https://www.wikidata.org/wiki/Q2376264","display_name":"Synucleinopathies","level":5,"score":0.789042592048645},{"id":"https://openalex.org/C2781449126","wikidata":"https://www.wikidata.org/wiki/Q288591","display_name":"Alpha-synuclein","level":4,"score":0.7332968711853027},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.6123377084732056},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.5603872537612915},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.5424748659133911},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.49150311946868896},{"id":"https://openalex.org/C2780043585","wikidata":"https://www.wikidata.org/wiki/Q7086841","display_name":"Oligopeptidase","level":3,"score":0.4853574335575104},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47946274280548096},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.46876853704452515},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4659745395183563},{"id":"https://openalex.org/C136238340","wikidata":"https://www.wikidata.org/wiki/Q7251455","display_name":"Protein aggregation","level":2,"score":0.45125189423561096},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35743895173072815},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2486082911491394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18619677424430847},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.14324957132339478},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14158040285110474},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13200777769088745},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.06505382061004639},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000085822","descriptor_name":"Prolyl Oligopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000409","descriptor_name":"Alanine","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001343","descriptor_name":"Autophagy","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001343","descriptor_name":"Autophagy","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001927","descriptor_name":"Brain Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001927","descriptor_name":"Brain Diseases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002461","descriptor_name":"Cell Line, Transformed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051844","descriptor_name":"alpha-Synuclein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051844","descriptor_name":"alpha-Synuclein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.nbd.2014.04.003","doi":"https://doi.org/10.1016/j.nbd.2014.04.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nbd.2014.04.003","pdf_url":null,"source":{"id":"https://openalex.org/S35878148","display_name":"Neurobiology of Disease","issn_l":"0969-9961","issn":["0969-9961","1095-953X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurobiology of Disease","raw_type":"journal-article"},{"id":"pmid:24746855","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24746855","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurobiology of disease","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7254878","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7254878","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Neurobiol Dis","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c7bcb981635d436dbabcfad7192b26e0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c7bcb981635d436dbabcfad7192b26e0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurobiology of Disease, Vol 68, Iss , Pp 1-15 (2014)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7254878","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7254878","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Neurobiol Dis","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7799999713897705,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2567797943","display_name":null,"funder_award_id":"138127","funder_id":"https://openalex.org/F4320321108","funder_display_name":"Academy of Finland"},{"id":"https://openalex.org/G6302148291","display_name":null,"funder_award_id":"267788","funder_id":"https://openalex.org/F4320321108","funder_display_name":"Academy of Finland"},{"id":"https://openalex.org/G8558697662","display_name":"Gene Therapy And Neurodegeneration","funder_award_id":"ZIADA000443","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320306186","display_name":"MetLife Foundation","ror":"https://ror.org/01c3dm486"},{"id":"https://openalex.org/F4320310223","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60"},{"id":"https://openalex.org/F4320321108","display_name":"Academy of Finland","ror":"https://ror.org/05k73zm37"},{"id":"https://openalex.org/F4320322282","display_name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","ror":"https://ror.org/03vxy9y38"},{"id":"https://openalex.org/F4320331730","display_name":"Suomen Farmaseuttinen Yhdistys","ror":"https://ror.org/02hv7zh11"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":85,"referenced_works":["https://openalex.org/W1487661483","https://openalex.org/W1532433391","https://openalex.org/W1536810742","https://openalex.org/W1541699778","https://openalex.org/W1572679174","https://openalex.org/W1608453139","https://openalex.org/W1760596310","https://openalex.org/W1764151989","https://openalex.org/W1832700959","https://openalex.org/W1965778124","https://openalex.org/W1967111894","https://openalex.org/W1968014007","https://openalex.org/W1974645020","https://openalex.org/W1975344451","https://openalex.org/W1979319226","https://openalex.org/W1980011561","https://openalex.org/W1986625112","https://openalex.org/W1986628169","https://openalex.org/W1989984498","https://openalex.org/W1991692801","https://openalex.org/W1997071370","https://openalex.org/W1997326851","https://openalex.org/W1999159261","https://openalex.org/W2002502410","https://openalex.org/W2009556855","https://openalex.org/W2011719513","https://openalex.org/W2012933599","https://openalex.org/W2013313629","https://openalex.org/W2017096262","https://openalex.org/W2017399629","https://openalex.org/W2019863741","https://openalex.org/W2023638441","https://openalex.org/W2024281265","https://openalex.org/W2026412511","https://openalex.org/W2026777107","https://openalex.org/W2031982078","https://openalex.org/W2037309642","https://openalex.org/W2037574006","https://openalex.org/W2037616229","https://openalex.org/W2049798717","https://openalex.org/W2050786534","https://openalex.org/W2051098162","https://openalex.org/W2052004580","https://openalex.org/W2052029497","https://openalex.org/W2054036316","https://openalex.org/W2057274775","https://openalex.org/W2057358353","https://openalex.org/W2058698021","https://openalex.org/W2059261643","https://openalex.org/W2060568634","https://openalex.org/W2062408667","https://openalex.org/W2062682736","https://openalex.org/W2065978481","https://openalex.org/W2068288454","https://openalex.org/W2071087722","https://openalex.org/W2073861040","https://openalex.org/W2076163934","https://openalex.org/W2077044335","https://openalex.org/W2077731318","https://openalex.org/W2080949995","https://openalex.org/W2081878678","https://openalex.org/W2082796078","https://openalex.org/W2082869146","https://openalex.org/W2087013895","https://openalex.org/W2087920955","https://openalex.org/W2088560909","https://openalex.org/W2091265794","https://openalex.org/W2093236269","https://openalex.org/W2093637710","https://openalex.org/W2109955285","https://openalex.org/W2110425683","https://openalex.org/W2112399469","https://openalex.org/W2113443121","https://openalex.org/W2123431154","https://openalex.org/W2131089732","https://openalex.org/W2144522321","https://openalex.org/W2150656456","https://openalex.org/W2153441656","https://openalex.org/W2154737306","https://openalex.org/W2166113206","https://openalex.org/W2170128458","https://openalex.org/W2273901504","https://openalex.org/W2324205500","https://openalex.org/W4295994768","https://openalex.org/W6666447612"],"related_works":["https://openalex.org/W3026560699","https://openalex.org/W1487661483","https://openalex.org/W3089094591","https://openalex.org/W2560138349","https://openalex.org/W2192731896","https://openalex.org/W4200057118","https://openalex.org/W2916852063","https://openalex.org/W2081030321","https://openalex.org/W2546550351","https://openalex.org/W2803123594"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}